Inovio Pharmaceuticals Inc (INO): Ino to test 100-dma of $5.11, then 200-d...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	3218
Boards Moderated	0
Alias Born	04/26/2007

Lakers_w

Re: None

Saturday, 03/19/2022 2:40:35 AM

Saturday, March 19, 2022 2:40:35 AM

Ino to test 100-dma of $5.11, then 200-dma of $6.66. Advaccine finished recruiting 267-ppl for Heterologous Booster 4800 after Sinovac on 1/27/22 before Lunar NewYear 2/1/22. China normally shuts down 2 weeks for celebration. So, Advaccine wasted no time. They are motivated to expedite the trials for IPO to get high valuation to fund global commercialization. Expect Interim Readout April 2022 for 2,4,6,8 wks After dosing. Updated: 3/9/22
Recruiting time: From2021-12-22 To 2022-01-27

http://www.chictr.org.cn/showproj.aspx?proj=131321&fbclid=IwAR1AVdMvFu74Nx8-pOSgRo4VjZMy7l0knDclViZlyOK_rPbfPJwTi2OfN64

https://mb.com.ph/2022/03/06/7083-participants-of-who-solidarity-trials-get-first-dose-of-covid-19-jabs/

3/6/22 Expect STV Interim Readout April 2022. “According to the STV team, the Philippines has already reached the primary outcome of the trial wherein 133 participants tested positive for Covid-19 after completing the two-dose schedule of the first study vaccine,” he noted.

According to DOST, the Philippines, Mali, and Colombia have reached the target number of primary endpoints and are currently validating and analyzing the initial data